Smokers
1
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Pierre FabreV0116 transdermal patch
SandozNIC002
MTIIsometric trunk exercises
Clinical Trials (3)
Total enrollment: 450 patients across 3 trials
Nicotine Patch Safety Study
Start: Aug 2012Est. completion: Oct 2012160 patients
Phase 2Completed
Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking.
Start: Aug 2008Est. completion: Oct 2009200 patients
Phase 2Completed
Isometric Versus Isotonic Trunk Muscle Strength Training on Lung Function in Heavy Smokers
Start: Oct 2025Est. completion: Jan 202690 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.